Country: United Kingdom
Language: English
Source: VMD (Veterinary Medicines Directorate)
Benethamine Penicillin, Framycetin Sulphate, Penethamate hydriodide, non-micronised
Boehringer Ingelheim Limited
QJ51RC25
Benethamine Penicillin, Framycetin Sulphate, Penethamate hydriodide, non-micronised
Intramammary suspension
POM-V - Prescription Only Medicine – Veterinarian
Cattle
Antimicrobial
Authorized
2011-12-13
Revised: May 2018 AN: 01982/2017 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT UK, IE Ubrostar Red 100 mg / 280 mg / 100 mg, Intramammary Suspension for cattle FR Ubrostar SUSPENSION INTRAMAMMAIRE HORS LACTATION POUR BOVINS BG, BE, CZ, HU, NL PL, RO, SK, SI Ubrostar DC 100 mg / 280 mg / 100 mg, Intramammary Suspension for cattle 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each 4.5 g intramammary syringe contains: ACTIVE SUBSTANCES: Penethamate Hydriodide 100 mg (equivalent to 77.2 mg penethamate) Benethamine Penicillin 280 mg (equivalent to 171.6 mg penicillin) Framycetin Sulphate 100 mg (equivalent to 71.0 mg framycetin) EXCIPIENTS: For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Intramammary suspension White to off white suspension. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle (at drying off). 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For treatment of subclinical mastitis at drying off, and the prevention of new bacterial infections of the udder during the dry period in dairy cows, caused by bacteria susceptible to penicillin and framycetin. 4.3 CONTRAINDICATIONS Do not use in lactating cows. Do not use in case of hypersensitivity to the active substances or to any of the excipients. Page 1 of 5 Revised: May 2018 AN: 01982/2017 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Where there is a risk of summer mastitis, additional management procedures, such as fly control should be considered. 4.5 SPECIAL PRECAUTIONS FOR USE Special precautions for use in animals Use of the product should be based on susceptibility testing of the bacteria isolated from the animal. If this is not possible, therapy should be based on local (regional, farm level) epidemiological information about susceptibility of the target bacteria. Official and local antimicrobial policies should be taken into account when the product is used. Serious acute mastitis [potentially lethal] due to pathogens like _Pseudomonas _ _aeruginosa_, can occur after drying off despite prev Read the complete document